Kyntra Bio, Inc. KYNB
3.73 USD +0.07 (+1.91%)
At closeNov 6, 2026, 4:00 PM EST
3.69 -0.04 -1.13%
After hours · Nov 6, 4:00 PM ET
3.61 Day range 3.88
3.66 52-week range 11.03
- YTD
- -57.52%
- 1 year
- -66.09%
News
benzinga.com Maxim Group Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $35 Maxim Group analyst Michael Okunewitch initiates coverage on Kyntra Bio (NASDAQ:KYNB) with a Buy rating and announces Price Target of $35.
benzinga.com Lake Street Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $41 Lake Street analyst Daniel Brims initiates coverage on Kyntra Bio (NASDAQ:KYNB) with a Buy rating and announces Price Target of $41.
benzinga.com HC Wainwright & Co. Reiterates Buy on Kyntra Bio, Maintains $43 Price Target HC Wainwright & Co. analyst Matthew Keller reiterates Kyntra Bio (NASDAQ:KYNB) with a Buy and maintains $43 price target.- benzinga.com Kyntra Bio To Reduce The Maximum Aggregate Payments Under Its Royalty Financing Agreement From $125M To $65M; Co. Accelerated Payment Of $42.6M Upfront, Bringing Total Payments Made To Date To $50M; Remaining Payments, Capped At $15M, To Be Paid From 50% Of The Revenue Received From Astellas In The Astellas Territories Excluding Japan Company reduces the maximum aggregate payments under its royalty financing agreement from $125 million to $65 million Company accelerated payment of $42.6 million upfront, bringing total payments…
benzinga.com UPDATE: Kyntra Bio Q2 Adj. EPS $(4.68) Misses $(3.18) Estimate, Sales $(1.474M) Miss $2.007M Estimate Kyntra Bio (NASDAQ:KYNB) reported quarterly losses of $(4.68) per share which missed the analyst consensus estimate of $(3.18) by 47.17 percent. This is a 148.94 percent decrease over losses of…
benzinga.com Kyntra Bio Q2 2026 Earnings Call: Complete Transcript On Thursday, Kyntra Bio (NASDAQ:KYNB) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings…
benzinga.com This Performance Food Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Wall Street analysts changed outlook on top names. See analyst rating changes on top stocks. PFGC, SPCX, KC, WELL, KYNB have coverage initiated.- benzinga.com Oppenheimer Initiates Coverage On Kyntra Bio with Outperform Rating, Announces Price Target of $35 Oppenheimer analyst Jay Olson initiates coverage on Kyntra Bio (NASDAQ:KYNB) with a Outperform rating and announces Price Target of $35.
benzinga.com Earnings Scheduled For May 11, 2026 - benzinga.com Earnings Scheduled For March 16, 2026